Bill > SB933

This bill, known as the "Right to Try for Individualized Treatments Act," establishes a framework for eligible patients with life-threatening or severely debilitating illnesses to access personalized investigational treatments that are uniquely developed for them based on their genetic profile, such as individualized gene therapy or neoantigen vaccines. An "eligible patient" must have exhausted all FDA-approved options, receive a physician's recommendation for such a treatment based on their genetic analysis, and provide written, informed consent detailing potential outcomes and financial responsibilities, acknowledging that insurance or government programs are not obligated to cover these treatments. The act makes it voluntary for manufacturers to offer these treatments and for healthcare providers and facilities to participate, while also granting them immunity from civil liability if they act in good faith and with reasonable care. Importantly, this legislation does not expand existing insurance coverage requirements, nor does it compel any state entity or licensed healthcare provider to facilitate or pay for these treatments, though it protects healthcare providers from disciplinary action for recommending them and prohibits state officials from blocking patient access.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb933&Session=2600